top of page

Abstract Submission

Thank you for your interest in participating in the

12th International Symposium on In Vivo Body Composition Studies (ISBCR 2025)

taking place in Auckland, New Zealand on 20-22 February 2025.

 

Please use the template provided and ensure you read the following guidance before submitting your abstract. 

Abstracts that do not conform with these guidelines will not be accepted for presentation at the conference.

Themes

Whilst ISBCR 2025 invites abstract submissions in any area of body composition research, for the purposes of assessment and programming, abstracts should be aligned to one of the following themes:

  • Application of Body Composition Assessment in Clinical Practice

  • Body Composition Analysis: Evolving Techniques and Biomedical Research

  • Body Composition in Sports & Physical Activity

  • Diversity, Equity & Inclusion in Body Composition Research

  • Other

 

Presentation Types

Delegates will be able to specify their preference for consideration of their abstract as either an oral or poster presentation. Both are equally valued contributions. Different presentation formats may be best suited to different kinds of content. Delegates are encouraged to choose their preferred presentation format. However, the final presentation type will be determined by the ISBCR 2025 organising committee. Following assessment by the committee, presenting authors will be notified by email confirming abstract acceptance and determined presentation type and providing the relevant presentation guidelines.

Please note that all presentations (poster and oral) will be in person in Auckland, New Zealand. The presenting author of each accepted abstract will be expected to register as a conference delegate by the due date. Failure to register will result in removal of your presentation from the conference programme.

 

Timeline

  • 16 August 2024: Submissions for consideration as oral presentations due.

  • 20 September 2024: Authors who submitted prior to 16 Aug notified.

  • 1 November 2024: Submissions for poster-only presentations due.

  • 15 November 2024: All remaining authors notified.

Submitting Your Abstract

Each submission should adhere to the abstract template provided and the document must be a Microsoft Word format. Abstracts submitted in other formats will be declined. Abstracts must be submitted online through the ISBCR portal and will not be accepted by fax, email or post. An automatic acknowledgement email will be sent once your abstract submission is complete.

 

General

  • Presenting authors must be specified at the time of abstract submission. This is the person all correspondence will be sent to, and, if accepted, this is the name that will appear in the conference programme. Authors must seek the approval of all co-authors before submitting an abstract for consideration and supply all names and affiliations

  • Pay careful attention to your wording and grammar as what you submit will be made available to conference delegates in the digital programme.

  • All abstracts MUST use People-First Language. Abstracts that do not use People-First Language will be rejected.

 

Formatting Requirements:

Title

The title should be:

  • Maximum 12 words

  • Arial font, 14 pt size

  • Left-justified alignment

  • Sentence case – first letter capitalised with subsequent letters in lower case, not all capitals and not title case

  • Abbreviations should not be used in the title.

  • Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.

Authors

The list of authors should be formatted as follows:

  • First Name Surname, with each author separated by a comma and the presenting author in bold, e.g., Jane Doe, John Smith, Joe Schmo.

  • Arial font, 11 pt size

  • Left-justified alignment

Authors can submit more than one abstract. However. when selecting your presenting author, we ask that all submissions reflect ISBCR 2025s commitment to diversity, equity and inclusion by encouraging a mix of presenting authors and speakers in terms of gender, ethnicity, career stage, institutional affiliation.

 

Affiliation(s)

At least one affiliation for each of the listed authors should be included, formatted as follows:

  • Arial font, 11 pt size

  • Left-justified alignment, italics

  • Affiliations should include department, institute, town and country.

  • Affiliations should be numbered sequentially in the order mentioned in the author list and NOT duplicated.

  • Affiliations should be separated using a semi-colon.

  • Each affiliation must be assigned to an author using Arabic numerals in superscript, e.g:

Jane Doe , John Smith , Joe Schmo

  University of Auckland, Auckland, New Zealand;  Monash University, Melbourne, Australia

 

Abstract Text

  • Arial font, 11 pt size

  • Single spaced

  • Justified alignment

  • Maximum of 250 words (this word count excludes the title, author details, conflicts of interest and funding statements).

  • Abstracts should be structured, and contain the following subheadings: Objective, Methods, Results (please be specific) and Conclusion.

  • Do not use footnotes or superscript numbers within the body of your abstract.

  • Pictures, tables and figures including graphs, are NOT allowed.

 

Disclosure Statement

All abstracts MUST be followed by a statement clearly declaring all potential conflicts of interest and funding sources related to the submitted work. If authors identify no conflicts of interest, they should declare this accordingly, e.g., “The authors declare no conflict of interest in relation to this work.”

 

Review Criteria

Before being accepted for presentation or poster, abstracts are reviewed by a scientific and editorial committee consisting of conference organisers, editors and peer reviewers. All submissions will be reviewed against the following criteria:

  • Relevance to the themes and aims of ISBCR 2025;

  • Originality of the work;

  • Overall quality, and scientific/clinical value.

1

2

1,2

1

2

bottom of page